Speaker Profile
M.D., President, GRAIL
Biography
Josh Ofman, MD, MSHS, is President at GRAIL. Josh serves as Chairman of the Board of Directors of EveryONE Medicines, a company dedicated to precision medicine for rare genetic diseases, and serves on the Board of the Precision Medicine Coalition. He has previously served on the Board of Directors of Cell BT, Inc, an immuno-therapy company.A physicianexecutive, Josh spent 15 years at Amgen leading Global Value, Access Policy as SVP. Prior to that Josh was on the UCLACedars-Sinai faculty and SVP at Cerners Zynx Health. He holds a BA (UC Berkeley), MD (UC Irvine), MSHS (UCLA), and completed internal medicine residency and digestive diseases fellowship and NRSARWJ research fellowship at UCLA.
Session Abstract – PMWC 2026 Silicon Valley
Track Chair: Victor Velculescu, Johns Hopkins
PMWC Award Ceremony
• Pioneer Honoree: Klaus Pantel, UKE & ELBS
• Luminary: Rebecca Fitzgerald, University of Cambridge
Keynote
• Klaus Pantel, UKE & ELBS
Advancing Minimal Residual Disease (MRD) Detection through cfDNA and cfRNA Profiling
• Chair: Luis Diaz, MSKCC
• Anne-Renee Hartman, Adela
Early Cancer Detection / Regulatory / Population Health
• Peter Bach, DELFI Diagnostics
• Joshua J. Ofman, GRAIL
Role of AI in Liquid Biopsies and Cancer Detection
• Chair: Amoolya Singh, DELFI Diagnostics
